top of page
Graphic Chart

A Transformative Breakthrough

A tested, proprietary chemistry platform that cuts costs and improves product performance in a growth industry

Profile summery

Corporate Profile Summary

​

  • We design, build and sell proprietary bio-tools: reagents and components for healthcare and bioprocessing
     

  • Gemina advances are a 'quantum leap' in Lateral Flow Assays

The Gemina Board

Stephen Shannon has over thirty years of investment experience, working with US family offices focused on real estate, private equity, oil and gas, banking and resources. He is based in the US where he is CEO of Shannon Capital Partners.

 

John Brussa is Chair and Partner at BD&P Law in Calgary, with expertise in taxation, corporate reorganisation, international transactions and structured finance. He is a Fellow in Business Management at Haskayne School of Business and a director of multiple public and private companies.

 

Martin Cronin spent over 20 years in international diplomacy with the British Government with appointments across the Middle East, South Asia, Europe and North America spanning counter-terrorism, conflict resolution, trade and inward investment. He has served as CEO and Director of several public and private companies including Patriot One and Patronus.

 

Dr. James Tansey has spent over 20 years at the interface of academic research and entrepreneurship. He founded a number of companies and serves on the board of Dynacert, Vanadium Resources and Charitable Impact. His expertise is in innovation and sustainability. He was a member of Gemina’s original founding team and returned in 2026 as Chairman.

 

Rob Greene is the founder and CEO of Gemina and serves on the board of Anodyne Chemistries. He is a surface binding chemist.

Board Members

Gemina Labs News

Stay in touch with the latest news from Gemina Labs:

Corporate News

Corporate and Regulatory News is released to the press via Accesswire and can be accessed via mainstream finance news services such as Yahoo Finance. 

​

Our own news page is where you'll find corporate and regulatory news, appointments, organisation & people, operations and product news.

​

You'll also find us on LinkedIn.

  • LinkedIn

Get our news and presentations straight to your inbox

We won'sell or share your data - and you can unsubscribe at any time

 

Thanks for subscribing

Presentations and Documentation

19 February 2026

Notice of Meeting

19 February 2026

Notice of Meeting and Management Information Circular

19 February 2026

Proxy Form

19 February 2026

Financial Statement Request Form

Presentations & Documentations

Contacts

For all investor enquiries, please email investor@geminalabs.com​​

Investor contacts
bottom of page